152 related articles for article (PubMed ID: 38311687)
1. Injectable in situ cross-linking hyaluronan hydrogel for easier removal of posterior vitreous cortex in vitrectomy.
Hisatomi T; Tachibana T; Mori K; Ishikawa K; Ishibashi T; Sonoda KH; Uchio E; Watanabe I; Suzuki K; Iida M
Jpn J Ophthalmol; 2024 Mar; 68(2):146-156. PubMed ID: 38311687
[TBL] [Abstract][Full Text] [Related]
2. Development of in situ crosslinked hyaluronan as an adjunct to vitrectomy surgery.
Suzuki K; Watanabe I; Tachibana T; Mori K; Ishikawa K; Ishibashi T; Uchio E; Sonoda KH; Hisatomi T
J Mater Sci Mater Med; 2023 Nov; 34(11):56. PubMed ID: 37930485
[TBL] [Abstract][Full Text] [Related]
3. Triamcinolone acetonide facilitates removal of the epiretinal membrane and separation of the residual vitreous cortex in highly myopic eyes with retinal detachment due to a macular hole.
Yamamoto N; Ozaki N; Murakami K
Ophthalmologica; 2004; 218(4):248-56. PubMed ID: 15258413
[TBL] [Abstract][Full Text] [Related]
4. Double visualization using triamcinolone acetonide and trypan blue during stage 3 macular hole surgery.
Yamamoto N; Ozaki N; Murakami K
Ophthalmologica; 2004; 218(5):297-305. PubMed ID: 15334009
[TBL] [Abstract][Full Text] [Related]
5. VITRECTOMY WITHOUT INNER LIMITING MEMBRANE PEELING FOR MACULAR RETINOSCHISIS IN HIGHLY MYOPIC EYES.
Qi Y; Duan AL; Meng X; Wang N
Retina; 2016 May; 36(5):953-6. PubMed ID: 26529553
[TBL] [Abstract][Full Text] [Related]
6. Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.
Sonoda KH; Sakamoto T; Enaida H; Miyazaki M; Noda Y; Nakamura T; Ueno A; Yokoyama M; Kubota T; Ishibashi T
Ophthalmology; 2004 Feb; 111(2):226-30. PubMed ID: 15019367
[TBL] [Abstract][Full Text] [Related]
7. Triamcinolone-assisted pars plana vitrectomy for retinal disease.
Zheng Y; Sun N; Xiong Q; Wang X; Quan Y
Yan Ke Xue Bao; 2005 Sep; 21(3):142-6. PubMed ID: 17162851
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of hyaloid-retinal relationship during triamcinolone-assisted vitrectomy for primary rhegmatogenous retinal detachment.
Sundar D; Takkar B; Venkatesh P; Chawla R; Temkar S; Azad SV; Vohra R
Eur J Ophthalmol; 2018 Sep; 28(5):607-613. PubMed ID: 29569478
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma - the ASCOT study.
Charteris DG; Cro S; Casswell E; Edwards RT; Ezeofor V; Anthony B; Bunce C; Robertson E; Kelly J; Murphy C; Banerjee P; Cornelius VR
Health Technol Assess; 2023 Jul; 27(12):1-50. PubMed ID: 37840322
[TBL] [Abstract][Full Text] [Related]
10. Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy.
Doi N; Uemura A; Nakao K; Sakamoto T
Retina; 2005 Sep; 25(6):742-5. PubMed ID: 16141862
[TBL] [Abstract][Full Text] [Related]
11. An injectable oxidated hyaluronic acid/adipic acid dihydrazide hydrogel as a vitreous substitute.
Su WY; Chen KH; Chen YC; Lee YH; Tseng CL; Lin FH
J Biomater Sci Polym Ed; 2011; 22(13):1777-97. PubMed ID: 20843434
[TBL] [Abstract][Full Text] [Related]
12. Removal of adherent cortical vitreous plaques without removing the internal limiting membrane in the repair of macular detachments in highly myopic eyes.
Spaide RF; Fisher Y
Retina; 2005; 25(3):290-5. PubMed ID: 15805905
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of intravitreal triamcinolone acetonide in the visualization of the vitreous during pars plana vitrectomy].
Mańkowska A; Rejdak R; Nowomiejska K; Zagórski Z
Klin Oczna; 2006; 108(1-3):24-7. PubMed ID: 16883934
[TBL] [Abstract][Full Text] [Related]
14. Visualizing vitreous in vitrectomy by triamcinolone.
Sakamoto T; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1153-63. PubMed ID: 19543906
[TBL] [Abstract][Full Text] [Related]
15. Biocompatibility and Efficacy of a Linearly Cross-Linked Sodium Hyaluronic Acid Hydrogel as a Retinal Patch in Rhegmatogenous Retinal Detachment Repairment.
Zheng C; Xi H; Wen D; Ke Y; Zhang X; Ren X; Li X
Front Bioeng Biotechnol; 2022; 10():914675. PubMed ID: 35860332
[TBL] [Abstract][Full Text] [Related]
16. Triamcinolone acetonide-assisted pars plana vitrectomy improves residual posterior vitreous hyaloid removal: ultrastructural analysis of the inner limiting membrane.
Matsumoto H; Yamanaka I; Hisatomi T; Enaida H; Ueno A; Hata Y; Sakamoto T; Ogino N; Ishibashi T
Retina; 2007 Feb; 27(2):174-9. PubMed ID: 17290199
[TBL] [Abstract][Full Text] [Related]
17. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
Ahmadieh H; Feghhi M; Tabatabaei H; Shoeibi N; Ramezani A; Mohebbi MR
Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876
[TBL] [Abstract][Full Text] [Related]
18. Effect on rabbits' intraocular structure by cross-linked hyaluronic formations as vitreous substitute.
Gong Y; Chen K; Wu Y; Guo XH; Zhang T
Int J Ophthalmol; 2020; 13(10):1531-1537. PubMed ID: 33078101
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy.
Liao M; Huang Y; Wang J; Meng X; Liu Y; Yu J; Yan H
Br J Ophthalmol; 2023 Apr; 107(4):560-564. PubMed ID: 34844917
[TBL] [Abstract][Full Text] [Related]
20. Comparison of triamcinolone acetonide, 11-deoxycortisol and other lipid formulae for the visualization of vitreous body in the anterior chamber after posterior capsule rupture in animal models.
Kaji Y; Hiraoka T; Okamoto F; Asano H; Oshika T
Acta Ophthalmol; 2008 Feb; 86(1):97-102. PubMed ID: 17908254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
